Innova Biopharmaceuticals

📍 Colombia🗓 Founded 2015💰 Last funded Jan 2015
Pharmaceutical Manufacturing🌐 innovabio.co
Website LinkedIn
Established in the year 2015 Innova biopharmaceuticals is a proud Colombian company which focuses on the commercialization of novel phytotherapeutics products in Colombia and South America. We locate and bring innovative products from leading R&D based companies around the world such as unique formulations and dosage forms on a licensing and partnering basis. Innova’s approach is establishing international collaborations, enabling us to deliver our costumes with unique, effective and innovative products. There is still a major unmet need in the standardization, optimization and delivery of effective, convenient and safe phytotheraupatic products . Innova partners, each of them a leading expert in their field cover together the entire scope of the skills required to deal with the company's strategic targets. ​ Innova Biopharmaceuticals vision is to lead the high end cannabis derived API’s. currently designing and building a state of the art extraction and purification facility with a production capacity of up to 150 tons of cannabis oil per Year.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2015
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Israel
1
Frequently asked questions
Who invested in Innova Biopharmaceuticals?
Innova Biopharmaceuticals has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Innova Biopharmaceuticals last raise funding?
The most recent investment in Innova Biopharmaceuticals recorded on gritt.io was in January 2015.
When was Innova Biopharmaceuticals founded?
Innova Biopharmaceuticals was founded in 2015.
What industry is Innova Biopharmaceuticals in?
Innova Biopharmaceuticals operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Innova Biopharmaceuticals based?
Innova Biopharmaceuticals is headquartered in Colombia.